231 related articles for article (PubMed ID: 35035657)
1. Methylation Pattern Mediated by m
Jiang F; Hu Y; Liu X; Wang M; Wu C
Oxid Med Cell Longev; 2022; 2022():2930310. PubMed ID: 35035657
[TBL] [Abstract][Full Text] [Related]
2. m
Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis of m
Wu X; Bai Z
Sci Rep; 2021 Oct; 11(1):20921. PubMed ID: 34686691
[TBL] [Abstract][Full Text] [Related]
4. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Ye W; Huang T
PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
[TBL] [Abstract][Full Text] [Related]
5. Analysis of m
Zeng QC; Sun Q; Su WJ; Li JC; Liu YS; Zhang K; Yang LQ
Sci Rep; 2022 Nov; 12(1):20684. PubMed ID: 36450735
[TBL] [Abstract][Full Text] [Related]
6. Characterization of m
Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
Front Immunol; 2021; 12():782551. PubMed ID: 34975871
[TBL] [Abstract][Full Text] [Related]
7. Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma.
Yang S; Li K; Zhang J; Liu J; Liu L; Tan Y; Xu C
Exp Biol Med (Maywood); 2023 Dec; 248(23):2273-2288. PubMed ID: 38166412
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma.
Wan RJ; Bai L; Jiang J; Hu CP; Chen Q; Zhao BR; Zhang Y; Li YY
Gene; 2022 Aug; 836():146639. PubMed ID: 35700805
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
[TBL] [Abstract][Full Text] [Related]
10. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
11. M
Chen H; Ge XL; Zhang ZY; Liu M; Wu RY; Zhang XF; Xu LP; Cheng HY; Sun XC; Zhu HC
Transl Lung Cancer Res; 2021 May; 10(5):2172-2192. PubMed ID: 34164268
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of m
Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Liu L; Jiang T
Front Genet; 2022; 13():996950. PubMed ID: 36246663
[No Abstract] [Full Text] [Related]
13. Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m
Zhou B; Gao S
Front Immunol; 2021; 12():698236. PubMed ID: 34650549
[TBL] [Abstract][Full Text] [Related]
14. Vasculogenic mimicry-associated novel gene signature predicted prognosis and response to immunotherapy in lung adenocarcinoma.
Zhang L; Wu J; Yin WW; Hu J; Liao L; Ma J; Xu Z; Wu S
Pathol Res Pract; 2024 Jan; 253():155048. PubMed ID: 38147724
[TBL] [Abstract][Full Text] [Related]
15. Integrated Analyses of m
Cao Q; Chen Y
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232485
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of N6-Methyladenosine (m
Liu D; Yuan M; Wang Z; Sun L; Fang Y; Ma X; Zhang L; Xing Y; Zhu J; Liu Y; Zhu W; Bao S; Jia Y; Wang Y
Can J Gastroenterol Hepatol; 2022; 2022():3506518. PubMed ID: 36452120
[TBL] [Abstract][Full Text] [Related]
17. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
[TBL] [Abstract][Full Text] [Related]
18. The Role of m6A Regulator-Mediated Methylation Modification and Tumor Microenvironment Infiltration in Glioblastoma Multiforme.
Wang L; Cao H; Zhong Y; Ji P; Chen F
Front Cell Dev Biol; 2022; 10():842835. PubMed ID: 35265626
[TBL] [Abstract][Full Text] [Related]
19. Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy.
Zhao B; Xiang Z; Wu B; Zhang X; Feng N; Wei Y; Zhang W
Curr Pharm Des; 2023; 29(1):60-78. PubMed ID: 36503445
[TBL] [Abstract][Full Text] [Related]
20. A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma.
Chang QH; Zhang YC; Zhang DY; Mao T; Chang R; Wang N; Ye Y; Xu ZJ
Aging (Albany NY); 2023 May; 15(9):3498-3523. PubMed ID: 37179124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]